Li‐Yu Wang

3.0k total citations · 1 hit paper
31 papers, 2.3k citations indexed

About

Li‐Yu Wang is a scholar working on Epidemiology, Hepatology and Pathology and Forensic Medicine. According to data from OpenAlex, Li‐Yu Wang has authored 31 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Epidemiology, 14 papers in Hepatology and 6 papers in Pathology and Forensic Medicine. Recurrent topics in Li‐Yu Wang's work include Liver Disease Diagnosis and Treatment (18 papers), Hepatitis B Virus Studies (18 papers) and Hepatitis C virus research (14 papers). Li‐Yu Wang is often cited by papers focused on Liver Disease Diagnosis and Treatment (18 papers), Hepatitis B Virus Studies (18 papers) and Hepatitis C virus research (14 papers). Li‐Yu Wang collaborates with scholars based in Taiwan, United States and Switzerland. Li‐Yu Wang's co-authors include Hwai‐I Yang, Chien‐Jen Chen, Sheng‐Nan Lu, San‐Lin You, Pei‐Jer Chen, Chuhsing Kate Hsiao, Ding‐Shinn Chen, Yun‐Fan Liaw, Chien‐An Sun and Ming‐Whei Yu and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Li‐Yu Wang

31 papers receiving 2.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Hepatitis B e Antigen and the Risk of Hepatocellular Carcinoma

2002 926 citations Hwai‐I Yang, Sheng‐Nan Lu et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Li‐Yu Wang Taiwan	21	1.8k	1.5k	207	179	153	31	2.3k
Li‐Yu Wang Taiwan	18	1.2k 0.7×	1.0k 0.7×	355 1.7×	86 0.5×	242 1.6×	26	1.7k
Michael Straßer Austria	19	1.0k 0.6×	807 0.5×	113 0.5×	108 0.6×	62 0.4×	47	1.5k
Gopal Krishna Dhali India	18	1.0k 0.6×	594 0.4×	372 1.8×	152 0.8×	201 1.3×	82	2.0k
Raul Aguilar Schall United States	15	1.8k 1.0×	1.6k 1.0×	142 0.7×	51 0.3×	94 0.6×	24	2.6k
Makoto Oketani Japan	24	1.1k 0.6×	1.2k 0.8×	248 1.2×	110 0.6×	60 0.4×	68	1.9k
Richard Sallie United States	21	1.4k 0.8×	1.4k 0.9×	241 1.2×	135 0.8×	17 0.1×	48	2.4k
So Young Kwon South Korea	22	988 0.6×	997 0.6×	122 0.6×	104 0.6×	51 0.3×	99	1.5k
Atsushi Naganuma Japan	21	428 0.2×	523 0.3×	188 0.9×	211 1.2×	65 0.4×	117	1.3k
Maneerat Chayanupatkul Thailand	18	1.4k 0.8×	1.1k 0.7×	303 1.5×	161 0.9×	155 1.0×	55	2.1k
Thomas Damgaard Sandahl Denmark	22	853 0.5×	594 0.4×	208 1.0×	81 0.5×	37 0.2×	79	1.5k

Countries citing papers authored by Li‐Yu Wang

Since Specialization

Citations

This map shows the geographic impact of Li‐Yu Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Li‐Yu Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Li‐Yu Wang more than expected).

Fields of papers citing papers by Li‐Yu Wang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Li‐Yu Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Li‐Yu Wang. The network helps show where Li‐Yu Wang may publish in the future.

Co-authorship network of co-authors of Li‐Yu Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Li‐Yu Wang. A scholar is included among the top collaborators of Li‐Yu Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Li‐Yu Wang. Li‐Yu Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hu, Hui-Han, Jessica Liu, Chin–Lan Jen, et al.. (2018). Level of Hepatitis B (HB) Core Antibody Associates With Seroclearance of HBV DNA and HB Surface Antigen in HB e Antigen-Seronegative Patients. Clinical Gastroenterology and Hepatology. 17(1). 172–181.e1. 25 indexed citations

Hu, Hui-Han, Jessica Liu, Yu‐Han Huang, et al.. (2018). A Glycomarker for Short-term Prediction of Hepatocellular Carcinoma: A Longitudinal Study With Serial Measurements. Clinical and Translational Gastroenterology. 9(9). e183–e183. 6 indexed citations

Liu, Chia‐Yu, et al.. (2018). Effects of green tea extract on overweight and obese women with high levels of low density-lipoprotein-cholesterol (LDL-C): a randomised, double-blind, and cross-over placebo-controlled clinical trial. BMC Complementary and Alternative Medicine. 18(1). 294–294. 65 indexed citations

Wang, Li‐Yu, et al.. (2017). Characterization of a transgenic mouse model exhibiting spontaneous lung adenocarcinomas with a metastatic phenotype. PLoS ONE. 12(4). e0175586–e0175586. 6 indexed citations

Huang, Chung‐Feng, Ming‐Lun Yeh, Pei‐Chien Tsai, et al.. (2017). Risk of hepatitis C virus related hepatocellular carcinoma between subjects with spontaneous and treatment-induced viral clearance. Oncotarget. 8(27). 43925–43933. 15 indexed citations

Liu, Jessica, Hui-Han Hu, Mei–Hsuan Lee, et al.. (2017). Serum Levels of M2BPGi as Short-Term Predictors of Hepatocellular Carcinoma in Untreated Chronic Hepatitis B Patients. Scientific Reports. 7(1). 14352–14352. 26 indexed citations

Liu, Jessica, Hwai‐I Yang, Mei–Hsuan Lee, et al.. (2016). Alcohol Drinking Mediates the Association between Polymorphisms of ADH1B and ALDH2 and Hepatitis B–Related Hepatocellular Carcinoma. Cancer Epidemiology Biomarkers & Prevention. 25(4). 693–699. 35 indexed citations

Hu, Hui-Han, Jessica Liu, Chia‐Lin Chang, et al.. (2015). The rs2296651 (S267F) variant on NTCP (SLC10A1) is inversely associated with chronic hepatitis B and progression to cirrhosis and hepatocellular carcinoma in patients with chronic hepatitis B. Gut. 65(9). 1514–1521. 78 indexed citations

Lee, Mei–Hsuan, Hwai‐I Yang, Sheng‐Nan Lu, et al.. (2015). Polymorphisms near the IFNL3 Gene Associated with HCV RNA Spontaneous Clearance and Hepatocellular Carcinoma Risk. Scientific Reports. 5(1). 17030–17030. 22 indexed citations

10.

Hsu, Wan‐Lun, Yin‐Chu Chien, Chun‐Ju Chiang, et al.. (2014). Lifetime risk of distinct upper aerodigestive tract cancers and consumption of alcohol, betel and cigarette. International Journal of Cancer. 135(6). 1480–1486. 26 indexed citations

11.

Yang, Hwai‐I, Chin–Lan Jen, San‐Lin You, et al.. (2013). Predictability of Liver-Related Seromarkers for the Risk of Hepatocellular Carcinoma in Chronic Hepatitis B Patients. PLoS ONE. 8(4). e61448–e61448. 38 indexed citations

12.

Liu, Jessica, Hwai‐I Yang, Mei–Hsuan Lee, et al.. (2013). Spontaneous seroclearance of hepatitis B seromarkers and subsequent risk of hepatocellular carcinoma. Gut. 63(10). 1648–1657. 129 indexed citations

13.

Liu, Jessica, Mei–Hsuan Lee, Richard Batrla‐Utermann, et al.. (2012). A predictive scoring system for the seroclearance of HBsAg in HBeAg-seronegative chronic hepatitis B patients with genotype B or C infection. Journal of Hepatology. 58(5). 853–860. 71 indexed citations

14.

Ho, Shu‐Chen, et al.. (2009). Fatal occupational injuries in Taiwan, 1994–2005. Occupational and Environmental Medicine. 67(4). 251–255. 8 indexed citations

15.

Iloeje, Uchenna H., Hwai‐I Yang, Chin–Lan Jen, et al.. (2009). Risk of pancreatic cancer in chronic hepatitis B virus infection: data from the REVEAL-HBV cohort study. Liver International. 30(3). 423–429. 67 indexed citations

16.

Wang, Li‐Yu, et al.. (2007). TT Virus Infection in Patients on Peritoneal Dialysis in Taiwan. Renal Failure. 29(5). 553–557. 1 indexed citations

17.

Wu, Hui-Chen, Qiao Wang, Hwai‐I Yang, et al.. (2007). Polycyclic aromatic hydrocarbon- and aflatoxin-albumin adducts, hepatitis B virus infection and hepatocellular carcinoma in Taiwan. Cancer Letters. 252(1). 104–114. 35 indexed citations

18.

Chang, Chih-Ching, Shu-Chen Ho, Li‐Yu Wang, & Chun‐Yuh Yang. (2007). Bladder Cancer in Taiwan: Relationship to Trihalomethane Concentrations Present in Drinking-Water Supplies. Journal of Toxicology and Environmental Health. 70(20). 1752–1757. 34 indexed citations

19.

Yang, Hwai‐I, Sheng‐Nan Lu, Yun‐Fan Liaw, et al.. (2002). Hepatitis B e Antigen and the Risk of Hepatocellular Carcinoma. New England Journal of Medicine. 347(3). 168–174. 926 indexed citations breakdown →

20.

Chen, Chien‐Jen, Li‐Yu Wang, & Ming‐Whei Yu. (2000). Epidemiology of hepatitis B virus infection in the Asia–Pacific region. Journal of Gastroenterology and Hepatology. 15(s2). E3–6. 221 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact